JP5443470B2 - 眼障害の治療方法 - Google Patents

眼障害の治療方法 Download PDF

Info

Publication number
JP5443470B2
JP5443470B2 JP2011506828A JP2011506828A JP5443470B2 JP 5443470 B2 JP5443470 B2 JP 5443470B2 JP 2011506828 A JP2011506828 A JP 2011506828A JP 2011506828 A JP2011506828 A JP 2011506828A JP 5443470 B2 JP5443470 B2 JP 5443470B2
Authority
JP
Japan
Prior art keywords
dominant
recessive
dystrophy
retinal
syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2011506828A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011518875A (ja
JP2011518875A5 (https=
Inventor
ミハエル・ベルキン
アヴィヴ・シャイシュ
ドロール・ハーツ
ガル・ローテンストレイチ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nikken Sohonsha Corp
Original Assignee
Nikken Sohonsha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nikken Sohonsha Corp filed Critical Nikken Sohonsha Corp
Publication of JP2011518875A publication Critical patent/JP2011518875A/ja
Publication of JP2011518875A5 publication Critical patent/JP2011518875A5/ja
Application granted granted Critical
Publication of JP5443470B2 publication Critical patent/JP5443470B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2011506828A 2008-04-29 2009-04-27 眼障害の治療方法 Active JP5443470B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US7144708P 2008-04-29 2008-04-29
US61/071,447 2008-04-29
US20233609P 2009-02-19 2009-02-19
US61/202,336 2009-02-19
PCT/IL2009/000448 WO2009133552A2 (en) 2008-04-29 2009-04-27 Methods of treating ophthalmic disorders

Publications (3)

Publication Number Publication Date
JP2011518875A JP2011518875A (ja) 2011-06-30
JP2011518875A5 JP2011518875A5 (https=) 2011-11-04
JP5443470B2 true JP5443470B2 (ja) 2014-03-19

Family

ID=40904160

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011506828A Active JP5443470B2 (ja) 2008-04-29 2009-04-27 眼障害の治療方法

Country Status (4)

Country Link
US (2) US8529907B2 (https=)
EP (1) EP2296682B8 (https=)
JP (1) JP5443470B2 (https=)
WO (1) WO2009133552A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009133552A2 (en) 2008-04-29 2009-11-05 Nikken Sohonsha Corporation Methods of treating ophthalmic disorders
EP2509611B1 (en) 2009-12-10 2016-03-02 Nikken Sohonsha Corporation Crude dunaliella powder for use in treating psoriasis
CN102973745A (zh) * 2012-11-30 2013-03-20 邢强强 用于治疗中心性视网膜炎的中药组合物及其制备方法
CN112153990A (zh) * 2018-03-23 2020-12-29 纽约市哥伦比亚大学理事会 用于常染色体显性疾病的基因编辑
CN108342323B (zh) * 2018-04-02 2021-11-19 大连理工大学 一种利用碳酸氢钠作为碳源的杜氏藻培养基及其应用
JP7773374B2 (ja) * 2019-04-01 2025-11-19 シェバ インパクト リミテッド 神経変性疾患、タンパク質ミスフォールディングに関連する障害及び認知機能低下の予防及び／又は治療のためのドナリエラ藻類製剤

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI920646A0 (fi) 1989-08-17 1992-02-14 Cortecs Ltd Farmaceutiska preparat.
IL119224A (en) * 1996-09-09 2002-11-10 Hadasit Med Res Service Medicament for protection from effects of irradiation
EP3326623A1 (en) * 2003-03-14 2018-05-30 University of Washington Retinoid replacements and opsin agonists and methods for the use thereof
US7264813B2 (en) * 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
NZ587006A (en) 2004-06-18 2011-12-22 Univ Washington 11-cis-Retinal derivatives and methods for the use thereof for the treatment of visual disorders
BRPI0515104A (pt) 2004-09-09 2008-07-08 Univ Washington método para produzir todo-trans-(13,14)-diidrorretinol, polipeptìdeo isolado, polinucleotìdeo isolado, construção de expressão, célula procariótica ou eucariótica cultivada, vetor, célula hospedeira isolada, método para produzir um polipeptìdeo retsat, anticorpo, método para identificar agonistas ou antagonistas de um polipeptìdeo retsat eucariótico, composição farmacêutica, e, métodos para tratar uma doença neoplásica em um indivìduo mamìfero, para tratar doença retinal ou cegueira em um indivìduo mamìfero, para tratar um estado de doença retinal ou cegueira em um indivìduo mamìfero, para tratar doença auto imune em um indivìduo mamìfero e para tratar uma condição ou distúrbio de pele em um indivìduo mamìfero
EP1861078A2 (en) * 2005-02-11 2007-12-05 Kalamazoo Holdings, Inc. A capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom
WO2006091796A2 (en) 2005-02-22 2006-08-31 Acucela, Inc. Compositions and methods for diagnosing and treating retinal diseases
WO2006091761A1 (en) 2005-02-24 2006-08-31 University Of Washington Methods for treatment of retinal degenerative disease
JP2007153842A (ja) 2005-12-07 2007-06-21 Hideki Aoki ビタミンアパタイト複合体
CA2644423A1 (en) * 2006-03-24 2007-10-04 Ian Simon Tracton Stable packaged dosage form and process therefor
WO2008063768A2 (en) 2006-10-12 2008-05-29 Case Western Reserve University Compositions and methods for treating metabolic diseases
WO2009133552A2 (en) 2008-04-29 2009-11-05 Nikken Sohonsha Corporation Methods of treating ophthalmic disorders
JP6063615B2 (ja) * 2008-04-29 2017-01-18 株式会社日健総本社 眼の医学的症状の治療用組成物

Also Published As

Publication number Publication date
US8529907B2 (en) 2013-09-10
WO2009133552A3 (en) 2010-03-18
EP2296682A2 (en) 2011-03-23
US20140023702A1 (en) 2014-01-23
WO2009133552A2 (en) 2009-11-05
EP2296682B8 (en) 2018-07-04
US8961993B2 (en) 2015-02-24
EP2296682B1 (en) 2018-04-11
JP2011518875A (ja) 2011-06-30
US20110045035A1 (en) 2011-02-24
WO2009133552A4 (en) 2010-05-06

Similar Documents

Publication Publication Date Title
Falsini et al. Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration
JP5443470B2 (ja) 眼障害の治療方法
Fishman et al. Diagnostic features of the Favre-Goldmann syndrome.
Girmens et al. Dry age-related macular degeneration: A currently unmet clinical need
Noble et al. Leber's congenital amaurosis: a retrospective study of 33 cases and a histopathological study of one case
Cogan et al. Ocular abnormalities in abetalipoproteinemia: a clinicopathologic correlation
Boulton Ageing of the retina and retinal pigment epithelium
CA3095468A1 (en) Use of (1s,3s)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (s)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of eye disorders
CN103566068B (zh) 具视网膜保护功能的复方组成物及应用
JP2011518875A5 (https=)
Das et al. Clinical management of eye diseases: carotenoids and their nanoformulations as choice of therapeutics
JP6063615B2 (ja) 眼の医学的症状の治療用組成物
Foulds The retinal-pigment epithelial interface.
Kremer et al. An unusual case of congenital unilateral Coats's disease associated with morning glory optic disc anomaly.
US20080275133A1 (en) Local Administration of Retinoids to Treat Deficiencies in Dark Adaptation
HK1149895A (en) Methods of treating ophthalmic disorders
HK1149895B (en) Methods of treating ophthalmic disorders
Cunha-Vaz Vitreous fluorophotometry recordings in posterior segment disease
RU2120264C1 (ru) Способ лечения транссудативных форм центральных хориоретинальных дистрофий
Das Prevention of visual loss in older adults
Wu et al. Hereditary hemorrhagic macular dystrophy
Heilig et al. Slow potentials of ERG in hemeralopia congenita
RU2857981C1 (ru) Способ комплексного лечения пигментного ретинита
Yamamoto et al. Mild retinal changes in a 47-year-old patient with phytanic acid storage disease
Khalil et al. Medical retina

Legal Events

Date Code Title Description
A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20110912

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110912

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130618

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130917

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20131119

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20131219

R150 Certificate of patent or registration of utility model

Ref document number: 5443470

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250